Search - tctmd.com

Displaying 261 - 280 of 1302

Sort: Relevancy | Date

Presentation TCT 2015

Ischemic Heart Disease and Acute Coronary Syndrome

Presenter: Hugh J. Linnehan, Bernard J. Gersh

October 13, 2015

Presentation TCT 2015

TCT 68: Safety and Efficacy of Stent Retriever for the Management of Acute Ischemic Stroke Comprehensive Review and Meta-analysis

Presenter: Mark C. Bates, Mark H. Wholey, Konstantinos Marmagkiolis

October 13, 2015

Presentation TCT 2015

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi

October 13, 2015

Presentation TCT 2015

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Presenter: Sigmund Silber, Philip M. Urban, Sorin J. Brener

October 13, 2015

Presentation TCT 2015

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

Presenter: Bernard J. Gersh, Stephen D. Wiviott, Giora Weisz

October 13, 2015

Presentation TCT 2015

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Presenter: David P. Faxon, David O. Williams, Martin W Bergmann

October 13, 2015

Presentation TCT 2015

CTSNet Ischemic MR Trial: Implications for Patient Management

Presenter: Michael A. Borger, Vinod H. Thourani

October 13, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

Presentation TCT 2015

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Presenter: Morton J. Kern, Jan J. Piek, Tim P. van de Hoef

October 12, 2015

News Industry News

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

October 12, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Presenter: Kevin J. Beatt, Craig R. Smith, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Presenter: Kevin J. Beatt, Craig R. Smith, David J. Maron

October 11, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

News Conference News TCT 2015

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

October 11, 2015

News Daily News

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

Yael L. Maxwell

October 09, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

Advertisement

Ischemic Heart Disease and Acute Coronary Syndrome

TCT 68: Safety and Efficacy of Stent Retriever for the Management of Acute Ischemic Stroke Comprehensive Review and Meta-analysis

TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial

TCT 59: The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After DES The ADAPT-DES study

Adjuvant Pharmacotherapy With Ranolazine In Patients With Ischemic Heart Disease

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

CTSNet Ischemic MR Trial: Implications for Patient Management

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

The Ischemic Continuum: What Is the Significance of a Lower FFR?

The Netherlands Presents: A Case Demonstration of Coronary Flow Capacity to Document Ischemic Heart Disease

Accessing the Heart Via the Arm During AD-HOC PCI has Similar Ischemic Outcomes Compared to Conventional Groin Access at One Year with Potential for Lower Bleeding

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? Yes, an Evidence-Based Position!

Debate: Should Most Patients With Stable Ischemic Heart Disease, Moderate or Greater Ischemia, and Controllable Symptoms Undergo Revascularization? The Data Says Not as a First-Line Therapy!

Use of LAA Occlusion in Low-Risk Patients Debated

Experts Debate Optimal Pharmacologic Approach for STEMI Patients

ADAPT-DES Substudy: Practice Changes May Decrease Already Low Stent Thrombosis Rates Even Further

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content